A founder factor VIII mutation, valine 2016 to alanine, in a population with an extraordinarily high prevalence of mild hemophilia A. • Arctic Health

It appears no script is enabled within your browser. Please enable JavaScript to use this site.

Home

View Selections: 0 Items Help

A founder factor VIII mutation, valine 2016 to alanine, in a population with an extraordinarily high prevalence of mild hemophilia A.

https://arctichealth.org/en/permalink/ahliterature191485

Source: Thromb Haemost. 2002 Jan;87(1):178-9

Publication Type: Article

Date: Jan-2002

Author: Y G Xie; H. Zheng; J. Leggo; M F Scully; D. Lillicrap

Source: Thromb Haemost. 2002 Jan;87(1):178-9

Date: Jan-2002

Language: English

Publication Type: Article

Keywords: Amino Acid Substitution; Codon - genetics; Exons - genetics; Factor VIII - chemistry - genetics; Founder Effect; Hemophilia A - epidemiology - genetics; Humans; Male; Mutation, Missense; Newfoundland and Labrador - epidemiology; Point Mutation; Prevalence; Protein Folding; Protein Structure, Tertiary; Structure-Activity Relationship; X Chromosome - genetics

PubMed ID: 11848452 View in PubMed